Frontier Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Frontier Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-98,927	Closed	-$2.83M	–	369
2015 Q2	$2.83M	Sell	98,927 -121	-0.1%	-$3.17K	0.02%	305
2015 Q1	$2.56M	Sell	99,048 -4,004	-4%	-$91.6K	0.02%	306
2014 Q4	$1.91M	Sell	103,052 -3,538	-3%	-$63.7K	0.01%	319
2014 Q3	$1.65M	Buy	+106,590	New	+$1.6M	0.01%	308

Other funds holding XENT

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frontier Capital Management's XENT Position: Q3 2015 in Review

Frontier Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2015, closing a stake of 98,927 shares — an estimated $2.83M sold.

Frontier Capital Management first reported a position in XENT in Q3 2014 and held it in 4 quarters. The position peaked at $2.83M in Q2 2015. 125 funds tracked by Wall St. Rank hold XENT as of Q3 2015.

Frontier Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2015 after selling out during the quarter.
Frontier Capital Management sold 98,927 Intersect ENT, Inc shares in Q3 2015, an estimated $2.83M.
Frontier Capital Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 4 quarters.
Frontier Capital Management's Intersect ENT, Inc position peaked at $2.83M in Q2 2015.
125 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2015.

Based on Frontier Capital Management's 13F filing for Q3 2015, filed 23 Oct 2015.